Valence Labs Overview
- Year Founded
-
2018

- Status
-
Acquired/Merged
- Employees
-
40

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$35.9M
Valence Labs General Information
Description
Developer of artificial intelligence-based drug discovery platform designed to unlock small and noisy datasets. The company's platform uses bioinformatics and artificial intelligence to optimize the development of drugs through predictive analytics and work with the small and noisy datasets characteristic of low-throughput compound screens and late-stage lead optimization, enabling pharmaceutical companies to reduce the time, design, and optimize novel ligands against a broad range of precision medicine targets.
Contact Information
Website
www.valencelabs.com(Operating Subsidiary)
Corporate Office
- Mila-Quebec's AI Institute
- 6666 Saint Urbain Street, Suite 200
- Montreal, Quebec H2S 3H1
- Canada
Corporate Office
- Mila-Quebec's AI Institute
- 6666 Saint Urbain Street, Suite 200
- Montreal, Quebec H2S 3H1
- Canada
Valence Labs Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
11. Merger/Acquisition | 16-May-2023 | $35.9M | Completed | Generating Revenue | ||
10. Seed Round | 19-Oct-2021 | Completed | Generating Revenue | |||
9. Accelerator/Incubator | 25-Nov-2019 | Completed | Generating Revenue | |||
8. Early Stage VC (Series 1) | 29-Sep-2019 | Completed | Generating Revenue | |||
7. Accelerator/Incubator | 01-Jan-2019 | Completed | Generating Revenue/Not Profitable | |||
6. Accelerator/Incubator | 10-Sep-2018 | Completed | Generating Revenue/Not Profitable | |||
5. Accelerator/Incubator | 08-Aug-2018 | Completed | Generating Revenue/Not Profitable | |||
4. Grant | 13-Jul-2018 | Completed | Generating Revenue/Not Profitable | |||
3. Seed Round | 01-Mar-2018 | $1.59M | $1.68M | Completed | Generating Revenue/Not Profitable | |
2. Accelerator/Incubator | 09-Jan-2018 | $94.7K | $94.7K | Completed | Generating Revenue/Not Profitable |
Valence Labs Signals
Valence Labs Former Investors (21)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Air Street Capital | Venture Capital | Minority | ||
Amplify Capital | Venture Capital | Minority | ||
Amplitude Ventures | Venture Capital | Minority | ||
BoxOne Ventures | Venture Capital | Minority | ||
Brian Karol | Angel (individual) | Minority |
Valence Labs FAQs
-
When was Valence Labs founded?
Valence Labs was founded in 2018.
-
Where is Valence Labs headquartered?
Valence Labs is headquartered in Montreal, Canada.
-
What is the size of Valence Labs?
Valence Labs has 40 total employees.
-
What industry is Valence Labs in?
Valence Labs’s primary industry is Drug Discovery.
-
Is Valence Labs a private or public company?
Valence Labs is a Private company.
-
What is the current valuation of Valence Labs?
The current valuation of Valence Labs is
. -
What is Valence Labs’s current revenue?
The current revenue for Valence Labs is
. -
How much funding has Valence Labs raised over time?
Valence Labs has raised $10.2M.
-
Who are Valence Labs’s investors?
Air Street Capital, Amplify Capital, Amplitude Ventures, BoxOne Ventures, and Brian Karol are 5 of 21 investors who have invested in Valence Labs.
-
When was Valence Labs acquired?
Valence Labs was acquired on 16-May-2023.
-
Who acquired Valence Labs?
Valence Labs was acquired by Recursion Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »